Pay in 4 interest-free payments of $6.43 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Review of high-risk factors Previous studies have shown that the development of DILI depends not only on the offending drug but also on host-related risk factors, including advanced age, female sex, pre-existing or concomitant liver disease, metabolic syndrome and diabetes, heavy alcohol use, polypharmacy, and genetic susceptibility mediated by specific HLA alleles ( For SJS/TEN, major risk factors include genetic susceptibility (e.g., HLA-B15:02, HLA-B58:01), HIV infection, malignancy or autoimmune disease, chronic renal impairment, older age, and exposure to high-risk medications such as antiepileptics, allopurinol, certain antibiotics, and NSAIDs ( -lactam antibiotics are among the most common culprit drugs for severe cutaneous adverse reactions (SCARs) ( Clinical implications This study provides an initial clinical characterization of concurrent DILI and SJS/TEN and proposes a hypothetical mechanism by which moxifloxacin may trigger mixed hepatic and cutaneous hypersensitivity reactions in the setting of prior PD-1 exposure
Fecal microbiota transplantation associated with 10 years of stability in a patient with SPMS
This study examined the effects of 14 days of l-carnitine l-tartrate oral supplementation (LC) on blood glucose, insulin, NEFA and GLP-1 responses to an oral glucose tolerance test (OGTT)
Conclusion Homocysteine (Hcy) is an important marker for checking metabolic health
Fraga MF, et al
Complexity: Injections require mixing and measurement
